Oncology Research and Treatment

Papers
(The median citation count of Oncology Research and Treatment is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution41
Decreased Incidence of Oncology Admissions in 75 Helios Hospitals in Germany during the COVID-19 Pandemic29
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 13. bis 16. Oktober 2023, Hamburg: Abstracts24
The Impact of Stereotactic or Whole Brain Radiotherapy on Neurocognitive Functioning in Adult Patients with Brain Metastases: A Systematic Review and Meta-Analysis22
35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin22
Why Do Our Cancer Patients Sleep So Badly? Sleep Disorders in Cancer Patients: A Frequent Symptom with Multiple Causes20
ERBB2 Pathway in Biliary Tract Carcinoma: Clinical Implications of a Targetable Pathway18
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien: Abstracts18
Long-Term Follow-Up of Children, Adolescents, and Young Adult Cancer Survivors16
Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article15
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (Hybrid-Kongress), 01.-04. Oktober 2021: Abstracts15
[18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-15
Established and Experimental Systemic Treatment Options for Advanced Liposarcoma14
A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events14
Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa Study14
Current Treatment Approaches to Newly Diagnosed Multiple Myeloma13
Liquid Biopsy in Metastatic Breast Cancer: Current Role of Circulating Tumor Cells and Circulating Tumor DNA13
Clinicopathological Features, Prognostic Factors, Survival Trends, and Treatment of Malignant Ovarian Germ Cell Tumors: A SEER Database Analysis13
Expression of BCRP/ABCG2 Protein in Invasive Breast Cancer and Response to Neoadjuvant Chemotherapy13
Effectiveness of Supportive-Expressive Group Therapy in Women with Breast Cancer: A Systematic Review and Meta-Analysis13
Targeting HER2 in Biliary Tract Carcinomas: Challenges and Opportunities13
Recent Advances in Castleman Disease12
Antibody-Drug Conjugates for Breast Cancer12
Prognostic Value of LRG1 in Breast Cancer: A Retrospective Study11
Neoadjuvant Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors Combined with Endocrine Therapy in HR+/HER2− Breast Cancer: A Systematic Review and Meta-Analysis10
No Impact of the Increased Number of Cardiovascular Risk Factors on Thrombosis and Survival in Polycythemia Vera10
Metronomic Chemotherapy for Metastatic Breast Cancer10
Current Research Status of Metronomic Chemotherapy in Combination Treatment of Breast Cancer9
BRAF V600E Mutation in Triple-Negative Breast Cancer: A Case Report and Literature Review9
Pancreatic Ductal Adenocarcinoma: New Insights into the Actions of Vitamin A8
Development of Skin Rash Predicts Outcome of Anti-PD-1- and Anti-CTLA4-Based Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer or Squamous Cell Carcinoma of the Head and Neck: A Single8
The Lung Immune Prognostic Index May Predict the Efficacy of Different Treatments in Patients with Advanced NSCLC: A Meta-Analysis8
Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study8
Awareness of Human Papillomavirus (HPV) and HPV Vaccination amongst the General Population in Germany: Lack of Awareness and Need for Action7
The Impact of Platinum-Containing Chemotherapies in Advanced Triple-Negative Breast Cancer: Meta-Analytical Approach to Evaluating Its Efficacy and Safety7
Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report7
Low Serological Prevalence of SARS-CoV-2 Antibodies in Cancer Patients at a German University Oncology Center7
Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein7
Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Adjuvant Setting for Patients with Resected Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer: A Meta-An7
Improving Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast or Colon Cancer after End of (Neo)adjuvant Therapy: Results from the Observational Study STEFANO7
Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment – Recommendations from an Expert Group from Austria, Germany, and Switzerland6
Comparative Analysis of Postoperative Complications after Cytoreductive Surgery and HIPEC in Gastric Cancer6
Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a <b><i>ROS1</i></b> p.L1950F Mutation: Case Report6
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review6
Incidence, Prevalence, and Real-World Treatment Patterns in Chronic Myeloid Leukemia: Results from a Population-Representative German Claims Data Analysis6
Comparative Safety and Efficacy of Therapeutic Options in Resectable and Advanced/Metastatic Pancreatic Cancer: A Systematic Review and Indirect Comparison6
Family Formation and Socio-Economic Status among 35-Year-Old Men Who Have Survived Cancer in Childhood and Early Adulthood: A Register-Based Cohort Study5
Current Role of Topoisomerase I Inhibitors for the Treatment of Mesenchymal Malignancies and Their Potential Future Use as Payload of Sarcoma-Specific Antibody-Drug Conjugates5
Shared Decision-Making in Oncology: Preferences in Older versus Younger Patients of an Oncology Clinic – A Conjoint Analysis5
Career and Professional Development for Young Oncologists5
Patterns of Treatment Failure after Concurrent Chemoradiotherapy or Adjuvant Radiotherapy in Patients with Locally Advanced Cervical Cancer5
The Preventive Effects of Boron-Based Gel on Radiation Dermatitis in Patients Being Treated for Breast Cancer: A Phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial5
Discoidin Domain Receptor 2: A New Target in Cancer5
Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell Transplantation5
Programmed Cell Death Protein 1 Blockade Elicits Ongoing Remission in 2 Cases of Refractory Epstein-Barr Virus-Associated Metastatic Gastric Carcinoma5
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation5
Regulation of miR-126 and miR-122 Expression and Response of Imatinib Treatment on Its Expression in Chronic Myeloid Leukemia Patients5
Preoperative Conization May Have a Positive Impact on Survival in Early-Stage Cervical Cancer: A Propensity-Matched Study5
Five-Fraction Stereotactic Radiotherapy for Brain Metastases: A Single-Institution Experience on Different Dose Schedules4
Abdominal Wall Reconstruction Using Omental Flap with Mesh Repair following Resection of Aggressive Abdominal Wall Neoplasms4
Significance of Patient-Reported Outcomes for Metastatic Breast Cancer Patients4
Clinicopathological and Prognostic Features of 67 Cases with Pulmonary Sarcomatoid Carcinoma: An 18-Year Single-Centre Experience4
Efficacy and Safety of Bevacizumab in Pretreated Metastatic Breast Cancer: A Systematic Review and Meta-Analysis4
Updated International Guidelines for Survivorship Care after Pediatric Cancer: Practice Implications in a German and Austrian Comprehensive Care Network4
Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors4
Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer4
Supportive Care Needs and the Impact of Loss of Functioning and Symptom Burden on the Quality of Life in Patients with Advanced Colorectal Cancer4
Contralateral Axillary Lymph Node Metastasis in a Patient with Relapsed Breast Cancer: Locoregional Event or Distant Metastasis Disease?4
Prognostic Value of Serum Apolipoprotein B to Apolipoprotein A-I Ratio in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis4
Male Breast Cancer: Therapy-Induced Toxicities, Psychological Distress, and Individual Patient Goals during Oncological Inpatient Rehabilitation3
The Study of Cerebral Blood Flow Variations during Brain Metastases Radiotherapy3
Medical Care and Survival of Soft-Tissue and Bone Sarcoma Patients: Results and Methodological Aspects of a German Subnational Cohort Study Based on Administrative Healthcare Data3
Sequential Geriatric Assessment in Older Patients with Colorectal Cancer during Chemotherapy: Subgroup Analysis of a Prospective, Multicenter Study EpiReal 753
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma3
Value of HSP90α in Lung Cancer Diagnosis and Recurrence Prediction: A Cohort Study3
Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approac3
Management of Oligometastatic Disease in Esophagogastric Cancer: What Is the Evidence?3
Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients3
Adjuvant Therapy in Resected Nonmetastatic Stage II–IV Gallbladder Cancer: A Generalized Propensity Score Analysis3
The Future Role of PET Imaging in Metastatic Breast Cancer3
Scalp Cooling for Prevention of Chemotherapy-Induced Alopecia for Women and Men with Various Cancer Entities: A Two-Year Survey of an Outpatient Cancer Center in Germany3
Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Pla3
The Burden of Fear of Cancer Recurrence in Genitourinary Cancers: A Prospective Study (NCT04535921)3
Bone Infarct-Associated Osteosarcoma: Epidemiologic and Survival Trends3
Recursive Partitioning Analysis of Systemic Therapy after Radiotherapy in Patients with Brain Metastases3
Enhanced LINC01061 Levels as a Serum Biomarker in Gastric Cancer and Promotion of Malignant Transformation3
Transferability of Health-Related Quality of Life Data of Large Observational Studies to Clinical Practice: Comparing Retroperitoneal Sarcoma Patients from the PROSa Study to a TARPS-WG Cohort3
Evidence Mapping of Proton Therapy, Heavy Ion Therapy, and Helical Tomotherapy for Gastric Cancer3
Vorwort des DGHO-Vorstandes3
Administration of Valproic Acid Improves the Survival of Patients with Glioma Treated with Postoperative Radiotherapy2
Venous Thromboembolism Prophylaxis with Low-Molecular-Weight Heparin in Primary Central Nervous System Lymphoma2
Curative Polyendocrine Therapy in a 21-year-Old Patient with Endometrial Carcinoma: Case Report and Review of the Literature2
Perspectives for Cancer Care and Research in Central and Eastern Europe2
Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort2
Prognosis Comparisons of Laparoscopy versus Open Surgery for Rectal Cancer Patients after Preoperative Chemoradiotherapy: A Meta-Analysis2
Treatment of Metastatic Colorectal Carcinoma with Bevacizumab in First-Line and beyond First Progression: The KORALLE Non-Interventional Cohort Study2
A Panel of Three Serum MicroRNAs as a Potential Diagnostic Biomarker for Urothelial Carcinoma2
Inflammatory Myofibroblastic Tumor in the Thyroid Gland: A Retrospective Case Series Study and Literature Review2
Acceptance and Benefits of Two Different Strategies to Timely Integrate Specialist Palliative Care into Routine Cancer Care: A Randomized Pilot Study2
Effect of Postoperative Radiotherapy in Thymoma Patients: A SEER-Based Study2
Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis2
Management of Synovial Sarcoma in a Tertiary Referral Center: A Retrospective Analysis of 134 Patients2
Klinische Studien in der Hämatologie und Onkologie2
Efficacy of Lutetium-Peptide Receptor Radionuclide Therapy in Inducing Prolonged Tumour Regression in Small-Bowel Neuroendocrine Tumours: A Case of Favourable Response to Retreatment after Initial Obj2
Seizures and Neuropsychiatric Toxicity in Patients with Non-Metastatic CRPC Treated with New Antiandrogens: Systematic Review and Meta-Analysis2
A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong2
Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database2
Efficacy and Safety of PD-1 Immune Checkpoint Inhibitors in Locally Advanced and Advanced Non-Small-Cell Lung Cancer Patients with Chronic Infection2
Does the Waiting Period for Genetic Tests Affect the Prognosis in Chemotherapy-Treated de novo Metastatic Non-Small Cell Lung Cancer Patients without a Driver Mutation?2
Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer2
Treatment Outcomes of Head and Neck Cancer Patients in the Elderly Receiving Different Chemoradiation Combinations: A Single-Center Experience2
The Poor Prognosis of Patients with Stage III Gastric Cancer after D2 Dissection Is Mainly due to Lymphatic Metastasis, Especially the Metastasis of No.12a LN: A Nested Case-Control Study2
Diagnostic Value of sST2, VCAM-1, and Adiponectin in Patients with Breast Cancer to Predict Anti-Tumour Treatment-Related Cardiac Events: A Pilot Study2
Retrospective Analysis of the Clinical Presentation, Treatment and Outcome of Angiosarcoma in a Sarcoma Referral Center2
Immune System Activation in Patients with Metastatic Renal Cell Carcinoma Induced by the Systemic Abscopal Effects of Radiation Therapy2
Risk and Prognosis of Subsequent Primary Gastric Cancer2
Exercise as Medicine Could Be a Chance for Early Detection and Prevention of Cardiotoxicity in Cancer Treatments: A Narrative Review2
PD-1 Blockade Elicits Ongoing Remission in Two Cases of Refractory Microsatellite-Stable Cancer Harboring a POLE Mutation2
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer2
The Importance of a Detailed Geriatric Functional Assessment of Older Patients with Cancer2
Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study2
Selective COX-2 Inhibitor Is Beneficial in Suppressing Chronic Postsurgical Pain in Esophageal Cancer Patients and May Prolong Patient Survival2
Stereotactic Radiotherapy for Adrenal Metastases: A Multi-Institutional Review of Patient Characteristics and Outcomes – Turkish Society for Radiation Oncology SBRT Group Study (Trod SBRT 10-004)2
Effects of Breast-Conserving Surgery and Mastectomy on the Survival of Patients with Early-Stage (T1-2N0-1M0) HER2-Positive Breast Cancer: A Propensity Score-Matched Analysis2
MLH1 Exon 12 Gene Deletion Leading to Lynch Syndrome: A Case Report2
Sequence Therapy with FOLFIRINOX and Gemcitabine/Nab-Paclitaxel for Patients with Advanced Pancreatic Cancer: A Monocentre Retrospective Cohort Study2
How an Oncologist’s Intuition Compares to a Geriatric Assessment2
Treatment of Metastatic Carcinoma of an Unknown Primary to the Heart with Checkpoint Inhibitor Therapy1
A Systematic Review for Evaluation of Specialized Programs for Addressing Young Women with Breast Cancer Problems1
Quality Measurement for Soft Tissue Sarcomas in Germany: First Results of the Certified Sarcoma Centres1
Management of Aortoesophageal Fistula in a Palliative Patient with Non-Small-Cell Lung Cancer: A Case Report1
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial1
Spirituality in Oncology: Relations between Spirituality, Its Facets, and Psychological and Demographic Factors in Cancer Patients in Germany1
Low Expression of miR-663a Indicates Poor Prognosis and Promotes Cell Proliferation, Migration, and Invasion in Breast Cancer1
Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling – A SEER Analysis1
A Taxonomy for Psycho-Oncological Intervention Techniques in an Acute Care Hospital in Germany1
Onkologie und Ökonomie – wie frei sind wir wirklich in der Behandlung von Patient*innen?1
Durable Responses to Chemotherapy in Patients with Metastatic Soft-Tissue Sarcoma1
Elective Discontinuation of CDK4/6 Inhibitors in Patients with Metastatic Hormone Receptor-Positive, Her-2-Negative Breast Cancer: A Retrospective Single-Center Experience1
Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany1
A Prospective Study on Defining the Indications of Prophylactic Level IB Radiotherapy in Nasopharyngeal Carcinoma Based on a Risk Score Model1
Sarcoma Research with Cancer Registry Data: Data and Peculiarities of Germany in the Light of Other Countries1
Efficacy and Safety of Lipegfilgrastim in Lung Cancer Patients Receiving Myelosuppressive Chemotherapy in a Real-World Setting: Results of an Analysis of Pooled Data from Two Non-Interventional Europe1
Clinical Impact of Structured Post-Operative Surveillance in Resected Pancreatic Adenocarcinoma: Results from a Retrospective Cohort Study1
Rituximab Treatment of Hairy Cell Leukemia in a Patient with <b><i>Mycobacterium kansasii</i></b> Infection: A Case Report1
Changes in Tumor Immune Microenvironment after Radiotherapy Resistance in Colorectal Cancer: A Narrative Review1
Clinical Features, Treatment Modalities, and Outcomes of Elderly Thymoma Patients: A Propensity-Matched Study Based on the SEER Database1
Oncologic Rehabilitation in the COVID-19 Pandemic: The Situation in Clinics1
Preliminary Clinical Validation of a Filtration-Based CTC Assay for Tumor Burden and HER2 Status Monitoring in Metastatic Breast Cancer1
Laser Interstitial Thermal Therapy in a Large Thalamic Glioma with Long-Term Remission: A Case Report1
Medical Oncology Education in Europe: Equipping Medical Oncologists to Provide the Best Care for Patients with Cancer1
New Opportunities in Advanced Breast Cancer1
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial1
An Unusual Case of Hypopituitarism as an Adverse Effect of Vandetanib and Remission of Breast Metastases in a Patient with Medullary Thyroid Cancer1
Impact of Geriatric Assessment on the Tolerability of Combination Chemotherapy in Older Patients with Advanced Cancer: A Matched-Pair Analysis1
Routine Cancer Treatment Regimens and Its Impact on Fine Motor Dexterity in Breast Cancer1
Effectiveness of Long-Term Treatment of Multiple Myeloma in Regular Care: Comparison of a Longitudinal and a Cross-Sectional Analysis Approach1
Prelims1
Curative, Organ-Sparing, Multimodal, Perioperative Treatment of a Young Patient with a Rectoanal Inflammatory Myofibroblastic Tumor1
Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice1
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience1
Contents Vol. 46, 20230
No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural Areas0
PharmaNews0
Front & Back Matter0
PharmaNews0
PharmaNews0
Society Bulletins0
Front & Back Matter0
Society Bulletins0
PharmaNews0
36. Deutscher Krebskongress. Fortschritt gemeinsam gestalten, 21.–24. Februar 2024, Berlin: ABSTRACTS0
CLL: Daten bestätigen Nutzen von Venetoclax-Kombinationstherapien0
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study0
PharmaNews0
Durvalumab-Immuntherapie: Dauer beeinflusste Erfolg0
uGI: Biomaker-Cut-Offs in der Immunonkologie0
Vorspann0
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center0
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study0
PharmaNews0
Front & Back Matter0
Comparison of the Efficacy, Safety, and Quality of Life of Pegylated Liposomal Doxorubicin-Cyclophosphamide versus Epirubicin-Cyclophosphamide in Patients with Early-Stage HER2-Negative Breast Cancer:0
Front & Back Matter0
Therapiemanagement nach einer CAR-T-Zell-Therapie0
Society Bulletins0
Front & Back Matter0
Prelims0
Ambulatory Routine Care in Oncology in Germany: Real-World Survival Data0
Mucinous Cystadenocarcinoma of the Breast with Bone Metastases: First Case Report and Literature Review0
A Population-Based and Propensity Score-Matched Investigation of the Occurrence, Management, and Prognosis of Anal Mucinous Adenocarcinoma Patients0
Zulassungserweiterung Yescarta beim r/r FL0
Front & Back Matter0
A Multicentre, Randomized Trial in Adults with de novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia to Assess the Efficacy of Ponatinib versus Imatinib in Combination with Low-Intens0
CTCL-Therapie mit Mogamulizumab0
Geriatric Assessment Scale for Optimal Management of Gastric Cancer in Older Adults Who Underwent Gastrectomy: A Systematic Review0
Front & Back Matter0
Society Bulletins0
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114)0
Erstlinien-IO-IO-Regime: 4-Jahres-OS-Rate bei 25%0
Prelims0
Society Bulletins0
Analysis of Burnout Prevalence among German Physicians Working in a Palliative Care Setting: A Survey of the AIO Quality of Life Working Group0
PharmaNews0
PharmaNews0
Contents Vol. 44, 20210
PharmaNews0
Atezolizumab beim operablen NSCLC0
Sacituzumab govitecan beim fortgeschrittenen Mammakarzinom0
Society Bulletins0
Society Bulletins0
PharmaNews0
Interview mit Prof. Paul G. Richardson, Boston, zu Melflufen0
Front & Back Matter0
ASCO Annual Meeting 2021: Neues zu PARP-, PD-1- und CDK4/6-Inhibitoren zur Therapie des Mammakarzinoms0
Hypogammaglobulinemia and Anti-CD20 Therapy-Induced Acute Thrombocytopenia: Perhaps More than a Coincidence?0
Oncolytic Activity of Canine Distemper Virus in Human Ductal Breast Carcinoma Cells0
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 20220
Aggressive B-Cell Lymphoma with Metastatic Spinal Cord Compression: Treat the Patient, Not the Disease0
PharmaNews0
Iptacopan: Erste orale PNH-Monotherapie0
Polypharmazie - Wechselwirkungen der BTKi0
Colorectal Cancer Highlights from the European Society for Medical Oncology Annual Meeting 20230
Society Bulletins0
PharmaNews0
OnkoImmun 200
Front & Back Matter0
Chronic Cutaneous Disorders Are Associated with a More Favorable Disease Presentation and Outcome in Patients with Hodgkin Lymphoma0
Cancer-Related Cognitive Dysfunction: A Narrative Review for Clinical Practice0
Front & Back Matter0
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 20230
OnkoImmun 170
Assessment and Evaluation of Psychosocial Distress in Outpatients with Cancer at a University Hospital in Germany0
Society Bulletins0
Oncology in Europe0
Society Bulletins0
Combining Poly-(ARD-Ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma0
KRAS – ein neuer prädiktiver Biomarker am Horizont0
EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis0
Gastroesophageal Oncology Highlights from the European Society for Medical Oncology Annual Meeting 20230
Extraskeletal Ewing Sarcoma of the Extremities and Trunk: A Retrospective Analysis of a Mono-Institutional Series0
Front & Back Matter0
OnkoImmun 140
Society Bulletins0
Multiples Myelom: Langzeitergebnisse der MAIA-Studie0
PharmaNews0
Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols0
Erratum0
Paclitaxel/Ramucirumab versus Paclitaxel in 2nd-Line Therapy of Advanced Esophageal Squamous Cell Carcinoma: Randomized Phase II IKF-AIO-RAMOS Trial0
Das inoperable NSCLC im Stadium III im Dialog0
0.05823278427124